#VisualAbstract: Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
1. This phase 3 trial of olaparib plus bevacizumab showed a significant progression-free survival benefit for ovarian cancer maintenance therapy. ...
Tag: bevacizumab (Avastin)
Olaparib plus bevacizumab for ovarian cancer maintenance therapy
1. This phase 3 trial of olaparib plus bevacizumab showed a significant progression-free survival benefit for ovarian cancer maintenance therapy. ...
Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma
Recent advances have been demonstrated with the administration of intraperitoneal (IP) cisplatin and paclitaxel, where women with stage III ovarian ...
Bevacizumab with induction and neoadjuvant chemoradiation may be effective in rectal cancer
1. In a phase II trial of T3 resectable rectal cancer, adding bevacizumab to induction and neoadjuvant chemoradiation resulted in ...